FSD1 inhibits glioblastoma diffuse infiltration through restriction of HDAC6-mediated microtubule deacetylation
Science China Life Sciences · 2025
DOI: 10.1007/s11427-024-2616-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science China Life Sciences, 2025. Verfasst von Dake Xiao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Nanhu Laboratory, National Center of Biomedical Analysis, Beijing, 100850, China. Hauptthemen laut MEDLINE: Glioblastoma, Histone Deacetylase 6, Microtubules, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The infiltration of glioblastoma multiforme (GBM) is predominantly characterized by diffuse spread, contributing significantly to therapy resistance and recurrence of GBM. In this study, we reveal that microtubule deacetylation, mediated through the downregulation of fibronectin type III and SPRY domain-containing 1 (FSD1), plays a pivotal role in promoting GBM diffuse infiltration. FSD1 directly interacts with histone deacetylase 6 (HDAC6) at its second catalytic domain, thereby impeding its deacetylase activity on α-tubulin and preventing microtubule deacetylation and depolymerization. This inhibitory interaction is disrupted upon phosphorylation of FSD1 at its Ser317 and Ser324 residues by activated CDK5, leading to FSD1 dissociation from microtubules and facilitating HDAC6-mediated α-tubulin deacetylation. Furthermore, increased expression of FSD1 or interference with FSD1 phosphorylation reduces microtubule deacetylation, suppresses invasion of GBM stem cells, and ultimately mitigates tumor infiltration in orthotopic GBM xenografts. Importantly, GBM tissues exhibit diminished levels of FSD1 expression, correlating with microtubule deacetylation and unfavorable clinical outcomes in GBM patients. These findings elucidate the mechanistic involvement of microtubule deacetylation in driving GBM cell invasion and offer potential avenues for managing GBM infiltration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanhu Laboratory, National Center of Biomedical Analysis, Beijing, 100850, China.
- School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China.
- Department of Neurosurgery, General Hospital of Central Theater Command of Chinese PLA, Wuhan, 430070, China.
- School of Life and Health Sciences, Huzhou College, Huzhou, 313000, China.
- Department of Neurosurgery, Beijing Fengtai Hospital, Beijing, 100070, China.
- Department of Neurosurgery, First Medical Center of PLA General Hospital, Beijing, 100853, China. leefangye@126.com.
Zitieren
APA
Xiao, D., Ran, H., Chen, L., Li, Y., Cai, Y., Zhang, S., Qi, Q., Wu, H., Zhang, C., Cao, S., Mi, L., Huang, H., Qi, J., Han, Q., Tu, H., Li, H., Zhou, T., Li, F., Li, A., & Man, J. (2025). FSD1 inhibits glioblastoma diffuse infiltration through restriction of HDAC6-mediated microtubule deacetylation. Science China Life Sciences. https://doi.org/10.1007/s11427-024-2616-7
Vancouver
Xiao D, Ran H, Chen L, Li Y, Cai Y, Zhang S, et al. FSD1 inhibits glioblastoma diffuse infiltration through restriction of HDAC6-mediated microtubule deacetylation. Science China Life Sciences. 2025. doi:10.1007/s11427-024-2616-7
BibTeX
@article{Xiao2025,
author = {Xiao, Dake and Ran, Haowen and Chen, Lishu and Li, Yuanyuan and Cai, Yan and Zhang, Songyang and Qi, Qinghui and Wu, Huiran and Zhang, Cheng and Cao, Shuailiang and Mi, Lanjuan and Huang, Haohao and Qi, Ji and Han, Qiuying and Tu, Haiqing and Li, Huiyan and Zhou, Tao and Li, Fangye and Li, Ailing and Man, Jianghong},
title = {FSD1 inhibits glioblastoma diffuse infiltration through restriction of HDAC6-mediated microtubule deacetylation},
journal = {Science China Life Sciences},
year = {2025},
doi = {10.1007/s11427-024-2616-7}
}
EUVIMED